Literature DB >> 10575162

Understanding research about quality of life and other health outcomes.

M M Chren1.   

Abstract

BACKGROUND: Papers reporting studies of health outcomes, particularly patients' perceptions, are becoming more common. Understanding the characteristics of tools used to measure these health outcomes is important for interpreting these studies accurately and applying them to clinical care.
OBJECTIVE: The purpose of this article is to describe important features of the measurement of patient-perceived health outcomes, and to illustrate how a consideration of these features can help in applying study results to individual patients.
CONCLUSION: Understanding the principles of measurement is particularly important for interpreting studies of dermatological care, in which patients' perceptions are a crucial outcome.

Entities:  

Mesh:

Year:  1999        PMID: 10575162     DOI: 10.1177/120347549900300608

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  3 in total

1.  Effect of store and forward teledermatology on quality of life: a randomized controlled trial.

Authors:  John D Whited; Erin M Warshaw; Karen E Edison; Kush Kapur; Lizy Thottapurathu; Srihari Raju; Bethany Cook; Holly Engasser; Samantha Pullen; Patricia Parks; Tom Sindowski; Danuta Motyka; Rodney Brown; Thomas E Moritz; Santanu K Datta; Mary-Margaret Chren; Lucinda Marty; Domenic J Reda
Journal:  JAMA Dermatol       Date:  2013-05       Impact factor: 10.282

2.  Reliability and validity of the Chinese version of the Psoriasis Disability Index (PDI) in Chinese patients with psoriasis.

Authors:  Zehui He; Chuanjian Lu; Aihua Ou; Jiqian Fang; Dongmei Wang; Jingwen Deng; Zhongzhao Zhang; Jingjie Yu
Journal:  Health Qual Life Outcomes       Date:  2012-04-13       Impact factor: 3.186

3.  Evaluation of QoL in neurofibromatosis patients: a systematic review and meta-analysis study.

Authors:  Akram Sanagoo; Leila Jouybari; Fatemeh Koohi; Fatemeh Sayehmiri
Journal:  BMC Neurol       Date:  2019-06-12       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.